VYGR
Voyager Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.13 / 10
Netural
Analyst coverage is limited but overwhelmingly bullish (1 Strong Buy, 0 others). Simultaneously, fund flow shows a 7.09/10 positive score with negative trends across block, small, medium, large, and extra-large patterns, hinting at underlying buying interest despite short-term outflows. This divergence between strong analyst conviction and mixed fund flows adds complexity to the near-term outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-12
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate50.0%
Is money flowing into or out of VYGR?
- VYGR holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.13/10 (Netural).
